Indefinite Delivery Contract HHSN272201000010I

Award Date 3/22/10
Last Date to Order 3/21/17
Ultimate Awardee
Not listed
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Emory University, a private research university. The contract has a ceiling value of $146,300,000 and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with the capability to develop, refine, and employ small animal models, non-human primate models, animal...
The indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Georgia Research Foundation, Inc. (UGA Research Foundation), a non-profit organization. The single-award IDC has a ceiling value of $146.3 million over 7 years and focuses on developing and employing animal and animal replacement models of infectious diseases to support NIAID's pandemic preparedness...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
The Indefinite Delivery Contract (IDC) 75N93024D00028 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Tennessee, a non-profit educational institution. The $146.3M contract has an ordering period ending in July 2031 and covers the development and use of animal and animal replacement models to evaluate candidate countermeasures (e.g., therapeutics, vaccines,...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Charles Stark Draper Laboratory, Inc. (Draper) for the development and employment of animal and animal replacement models of infectious diseases. The $146.3 million single-award IDC has a 7-year ordering period and supports the full range of preclinical evaluations, including screening, product evaluation, and eventual clinical evaluation of...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development and...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to the University of Southwestern Louisiana Inc. as the prime contractor. The contract provides for Veterinary/Animal Care Services under the NIAID's Division of Intramural Research (DIR) program. As a single-award IDC, it does not utilize any set-asides. The contract has a ceiling value of $0 and a...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The University of North Texas Health Science Center at Fort Worth (UNTHSC) as a single award with a $146,300,000 ceiling value and a period of performance through July 2031. The contract is for the provision of pre-clinical models of infectious diseases, including the development and refinement of small animal, non-human primate, and animal...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, has awarded a single-award Indefinite Delivery Contract (IDC) valued at $146.3 million to the University of Cincinnati. The contract, titled "Pre-Clinical Models of Infectious Diseases - Task Area A," has an ordering period through July 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop, refine, and employ...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Texas Medical Branch at Galveston (UTMB) to provide preclinical models and services for the development and evaluation of medical countermeasures against infectious diseases. The $146.3M single-award IDC has a 7-year ordering period and covers four task areas: (A) small animal...

This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Duke University's Office of Research Administration Division as the prime contractor. The $20,000,000 IDC falls under the NIAID Animal Models of Infectious Diseases 2010-2017 multiple-award IDIQ contract vehicle and does not have any set-aside designations.

Under this IDC, Duke University will provide a diverse array of biomedical research and services to NIAID, including conducting animal models of infectious diseases research. Two sample task orders have been issued to Duke totaling $50,000 for the provision of these animal models. The services are to be performed at Duke's facilities in Durham, North Carolina. This IDC award demonstrates Duke University's broad capabilities in delivering critical biomedical research and support services to federal government agencies across a range of scientific disciplines.

Generated 11/24/24, 9:11 AM